Tevogen Bio Holdings Inc. (TVGN)
NASDAQ: TVGN · Real-Time Price · USD
0.9800
-0.0300 (-2.97%)
Aug 14, 2025, 4:00 PM - Market closed
Tevogen Bio Holdings Employees
Tevogen Bio Holdings had 18 employees as of December 31, 2024.
Employees
18
Change
n/a
Growth
n/a
Revenue / Employee
n/a
Profits / Employee
-$1,738,041
Market Cap
189.82M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 18 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
TVGN News
- 8 hours ago - Tevogen to Release Internal Asset Valuation; CEO Affirms Assets Are Fully Protected - GlobeNewsWire
- 1 day ago - Repeat - Tevogen.AI Expands Collaboration With Databricks and Microsoft to Build the Beta Version of Its PredicTcell™ Model With a Focus on Oncology - GlobeNewsWire
- 3 days ago - Tevogen Bio Reaffirms Investor Confidence with Estimated Asset Value Exceeding $10 Billion - GlobeNewsWire
- 3 days ago - REPEAT -- Tevogen Bio Specialty Care Reports Top-Line Revenue Forecast of Nearly $1 Billion in Launch Year and Cumulative 5-Year Estimate Between $18 Billion and $22 Billion - GlobeNewsWire
- 3 days ago - Tevogen Bio Oncology Reports Top-Line Revenue Forecast of $1 Billion in Launch Year and Cumulative 5-Year Estimate Between $10 Billion and $14 Billion; Forecasts for Non-Oncology Therapeutic Areas to Follow - GlobeNewsWire
- 3 days ago - REPEAT - Tevogen CEO Affirms Strong Growth, Capital Position, and AI Expansion in Letter to Stockholders - GlobeNewsWire
- 6 days ago - REPEAT - Tevogen Sees Significant Institutional Ownership Growth; 73% of Holders Increase Positions - GlobeNewsWire
- 7 days ago - Tevogen Receives $1 Million to Accelerate AI-Driven Drug Discovery; Remains Well Capitalized to Execute Growth Strategy - GlobeNewsWire